Histogenics Corporation Garners $9,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5547a2a4-7653-4555-a866-d7e9087f0773&Preview=1 - Date
9/4/2008 - Company Name
Histogenics Corporation - Mailing Address
830 Winter Street, 3rd Floor Waltham, MA 02451 - Company Description
Histogenics Corporation’s approach to cartilage regeneration is to use a technology platform that employs advances in cell biology, tissue culture, engineering, and materials science to affect tissue repair. - Website
http://www.histogenics.com - Transaction Type
Venture Equity - Transaction Amount
$9,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Boston Millennia Partners - Venture Investor
Foundation Medical Partners - Venture Investor
Stryker Corporation
Trending on Xconomy
By posting a comment, you agree to our terms and conditions.
